# US 2013/0156859 A1 · Immunogenic composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156859 A1
- Document ID: US20130156859A1
- Status: Published application
- Kind: A1
- Application number: 13/819,015
- Filed: 2011-08-25
- Published: 2013-06-20
- Earliest claimed: 2010-08-26
- Assignees: Toray Industries, Inc.
- Inventors: Yoichiro Koshi; Reiji Nishio; Yoshinori Kakizawa
- Web page: https://patentgrep.com/patent/US20130156859A1

## CPC

- A61K 9/1682: {Processes}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/1641: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers}
- A61K 9/1647: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 39/0011: {Cancer antigens}
- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 2039/55583: {Polysaccharides}
- A61K 2039/6087: {Polysaccharides; Lipopolysaccharides [LPS]}
- A61K 2039/6093: {Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

An immunogenic composition includes as effective ingredients: an immunogenic micro-particle composed of an antigen-adjuvant microparticle complex wherein an antigen(s) is/are encapsulated in an adjuvant microparticle composed of an amphiphilic polymer(s) whose hydro-phobic segment(s) is/are poly(hydroxy acid); and a surfactant encapsulated in the immunogenic microparticle.

## Claims

### Claim 1

An immunogenic composition comprising as effective ingredients: an immunogenic microparticle composed of an antigen-adjuvant microparticle complex wherein an antigen(s) is/are encapsulated in an adjuvant microparticle composed of an amphiphilic polymer(s) whose hydrophobic segment(s) is/are poly(hydroxy acid); and a surfactant encapsulated in said immunogenic microparticle.

### Claim 2 (depends on 1)

The immunogenic composition according to claim 1, wherein said immunogenic microparticle is a particle composed of said antigen-adjuvant microparticle complex associated together.

### Claim 3 (depends on 1)

The immunogenic composition according to claim 1, wherein said surfactant comprises a fatty acid ester structure.

### Claim 4 (depends on 1)

The immunogenic composition according to claim 1, wherein said adjuvant microparticle has, in an inner portion thereof, a hydrophilic portion(s) composed of a hydrophilic segment(s) of said amphiphilic polymer(s), and has an outer layer composed of a hydrophobic portion(s) composed of a hydrophobic segment(s) of said amphiphilic polymer(s).

### Claim 5 (depends on 1)

The immunogenic composition according to claim 1, wherein said hydrophilic segment of said amphiphilic polymer is a polysaccharide.

### Claim 6 (depends on 1)

The immunogenic composition according to claim 1, wherein said amphiphilic polymer is a graft amphiphilic polymer composed of a polysaccharide backbone and a poly(hydroxy acid) graft chain(s).

### Claim 7 (depends on 5)

The immunogenic composition according to claim 5, wherein said polysaccharide is dextran.

### Claim 8 (depends on 1)

The immunogenic composition according to claim 1, wherein said poly(hydroxy acid) is poly(lactic-co-glycolic acid).

### Claim 9 (depends on 1)

The immunogenic composition according to claim 1, wherein said surfactant further comprises a monosaccharide and/or polyethylene glycol structure(s).

### Claim 10 (depends on 1)

The immunogenic composition according to claim 1, wherein said surfactant is one or more selected from the group consisting of polysorbate 80, polysorbate 20, sorbitan monooleate, sorbitan trioleate and polyoxyethylene hydrogenated castor oil.

### Claim 11

An immunogenic composition comprising as an effective ingredient an immunogenic microparticle obtained by:
dissolving a surfactant(s) in an aqueous solvent A wherein an antigen(s) is/are dissolved or in a water-immiscible organic solvent B wherein an amphiphilic polymer(s) whose hydrophobic segment(s) is/are poly(hydroxy acid) is/are dissolved, and mixing the resulting mixture to form a reversed-phase emulsion; and
removing the solvent from said reversed-phase emulsion.

### Claim 12

An immunogenic composition comprising as an effective ingredient an immunogenic microparticle obtained by a process of producing a particle composed of an antigen-adjuvant microparticle complex associated together, said process comprising:
mixing an aqueous solvent A wherein an antigen(s) is/are dissolved and a water-immiscible organic solvent B wherein an amphiphilic polymer(s) whose hydrophobic segment(s) is/are poly(hydroxy acid) is/are dissolved, to form a reversed-phase emulsion;
removing the solvent from said reversed-phase emulsion to obtain an antigen-adjuvant microparticle complex; and
introducing an antigen-adjuvant microparticle complex dispersion C to a liquid phase D wherein a surface modifier is dissolved, followed by removing the dispersion medium;
wherein a surfactant(s) is/are dissolved in said aqueous solvent A, water-immiscible organic solvent B and/or dispersion C.

### Claim 13 (depends on 2)

The immunogenic composition according to claim 2, wherein said surfactant comprises a fatty acid ester structure.

### Claim 14 (depends on 2)

The immunogenic composition according to claim 2, wherein said adjuvant microparticle has, in an inner portion thereof, a hydrophilic portion(s) composed of a hydrophilic segment(s) of said amphiphilic polymer(s), and has an outer layer composed of a hydrophobic portion(s) composed of a hydrophobic segment(s) of said amphiphilic polymer(s).

### Claim 15 (depends on 3)

The immunogenic composition according to claim 3, wherein said adjuvant microparticle has, in an inner portion thereof, a hydrophilic portion(s) composed of a hydrophilic segment(s) of said amphiphilic polymer(s), and has an outer layer composed of a hydrophobic portion(s) composed of a hydrophobic segment(s) of said amphiphilic polymer(s).

### Claim 16 (depends on 6)

The immunogenic composition according to claim 6, wherein said polysaccharide is dextran.

### Claim 17 (depends on 2)

The immunogenic composition according to claim 2, wherein said hydrophilic segment of said amphiphilic polymer is a polysaccharide.

### Claim 18 (depends on 3)

The immunogenic composition according to claim 3, wherein said hydrophilic segment of said amphiphilic polymer is a polysaccharide.

### Claim 19 (depends on 4)

The immunogenic composition according to claim 4, wherein said hydrophilic segment of said amphiphilic polymer is a polysaccharide.
